SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001493152-23-037344
Filing Date
2023-10-16
Accepted
2023-10-16 16:05:24
Documents
16
Period of Report
2023-10-16
Items
Item 2.01: Completion of Acquisition or Disposition of Assets
Item 3.03: Material Modifications to Rights of Security Holders
Item 5.01: Changes in Control of Registrant
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-k.htm   iXBRL 8-K 120788
2 ex3-1.htm EX-3.1 7867
3 ex10-4.htm EX-10.4 126304
4 ex99-1.htm EX-99.1 26499
5 ex99-1_001.jpg GRAPHIC 2891
  Complete submission text file 0001493152-23-037344.txt   503430

Data Files

Seq Description Document Type Size
6 XBRL SCHEMA FILE ntbl-20231016.xsd EX-101.SCH 3024
7 XBRL LABEL FILE ntbl-20231016_lab.xml EX-101.LAB 34240
8 XBRL PRESENTATION FILE ntbl-20231016_pre.xml EX-101.PRE 22365
10 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 3198
Mailing Address HASATAT 8 ST. MODI'IN, L3 7178106
Business Address HASATAT 8 ST. MODI'IN, L3 7178106 972-3-6346450
Notable Labs, Ltd. (Filer) CIK: 0001603207 (see all company filings)

IRS No.: 000000000 | State of Incorp.: L3 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36581 | Film No.: 231327392
SIC: 2834 Pharmaceutical Preparations